Close relationship between motor impairments and loss of functional motoneurons in a Charcot-Marie-Tooth type 1A model

Neuroscience

Volumn 116, Issue 3, 2003, Pages 695-703

  Norreel, J C ^a   Vinay, L ^a   Fontes, M ^b   Clarac, F ^a  

^a CNRS   (France)

^b TIMONE HOSPITAL   (France)

Author keywords

Motoneurons; Myelination; PMP22; Retrograde labeling; Transgenic mice

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TESTING ALTERNATIVE; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CHROMOSOME; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMYELINATION; EVALUATION; FUNCTIONAL DISEASE; GENE; GENETIC TRANSCRIPTION; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; MOUSE; MUSCULOSKELETAL SYSTEM; MYELIN SHEATH; MYELINATED NERVE; NEUROMUSCULAR SYNAPSE; NONHUMAN; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN MYELIN PERIPHERAL GENE; SENSORY DYSFUNCTION; THICKNESS; TRANSGENIC MOUSE;

EID: 0037450412     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(02)00741-8     Document Type: Article

References (36)

1. Adlkofer K., Martini R., Aguzzi A., Zielasek J., Toyka K.V., Suter U. Hypermyelination and demyelination peripheral neuropathy in PMP-22-deficient mice. Nat Genet. 11:1995;274-280.
2. Adlkofer K., Frei R., Neuberg D.H., Zielasek J., Toyka K.V., Suter U. Heterozygous peripheral myelin protein 22-deficient mice are affected by a progressive demyelinating tomaculous neuropathy. J Neurosci. 17:1997;4662-4671.
3. Berciano J.A., Garcia J., Calleja J., Combarros O. Clinico-electrophysiological correlation of extensor digitorum brevis muscle atrophy in children with Charcot-Marie-Tooth disease 1A duplication. Neuromuscul Disord. 10:2000;419-424.
4. Carenini S., Neuberg D., Schachner M., Suter U., Martini R. Localization and functional roles of PMP22 in peripheral nerves of P0-deficient mice. Glia. 28:1999;256-264.
5. Chapillon P., Lalonde R., Jones N., Caston J. Early development of synchronized walking on the rotorod in rats effects of training and handling . Behav Brain Res. 93:1998;77-81.
6. Chen Z.Y., Chai Y.F., Cao L., Lu C.L., He C. Glial cell line-derived neurotrophic factor enhances axonal regeneration following sciatic nerve transection in adult rats. Brain Res. 902:2001;272-276.
7. De Waegh S.M., Brady S.T. Altered slow axonal transport and regenetation in a myelin-deficient mutant mouse the trembler as an in vivo model for Schwann cell-axon interactions . J Neurosci. 10:1990;1855-1865.
8. De Waegh S.M., Lee V.M., Brady S.T. Local modulation of neurofilament phosphorylation, axonal caliber, and slow axonal transport by myelinating Schwann cells. Cell. 68:1992;451-463.
9. Dunham N.W., Miya T.S. A note on a simple apparatus for detecting neurological deficit in rats and mice. J Am Pharma Assoc. 46:1957;208-209.
10. D'Urso D., Ehrhardt P., Muller H.W. Peripheral myelin protein 22 and protein zero a novel association in peripheral nervous system myelin . J Neurosci. 19:1999;3396-3403.
11. Garcia C.A., Malamut R.E., England J.D., Lupski J.R. Clin variability in two pairs of identical twins with the Charcot-Marie-Tooth disease type 1A. Neurology. 45:1995;2090-2093.
12. Henderson C.E., Yamamoto Y., Livet J., Arce V., Garces A., de Lapeyrière O. Role of neurotrophic factors in motoneuron development. J Physiol (Paris). 92:1998;279-281.
13. Huxley C., Passage E., Manson A., Putzu G., Figarella-Branger D., Pelissier J.F., Fontes M. Construction of a mouse model of Charcot-Marie-Tooth disease type 1A by pronuclear injection of human YAC DNA. Hum Mol Genet. 5:1996;563-569.
14. Huxley C., Passage E., Robertson A.M., Youl B., Huston S., Manson A., Saberan-Djoniedi D., Figarella-Branger D., Pelissier J.F., Thomas P., Fontes M. Correlation between varying levels of PMP22 expression and the degree of demyelination and reduction in nerve conduction velocity in transgenic mice. Hum Mol Genet. 7:1998;449-458.
15. Krajewski K.M., Turansky C., Lewis R., Garbern J., Hinderer S.R., Kamholz J., Shy M.E. Correlation between weakness and axonal loss in patients with CMT1A. Ann NY Acad Sci. 883:1999;490-492.
16. Krajewski K.M., Lewis R.A., Fuerst D.R., Turanski C., Hinderer S.R., Garben J., Kamholz J., Shy M.E. Neurological dysfunction and axonal degeneration in Charcot-Marie-Tooth disease type 1A. Brain. 123:2000;1516-1527.
17. Lupski J.R., Wise C.A., Kuwano A. Gene dosage is a mechanism for Charcot-Marie-Tooth disease type 1A. Nature Genet. 1:1992;29-33.
18. Magyar J.P., Martini R., Ruelicke T., Aguzzi A., Adlkofer K., Dembic Z. Impaired differentiation of Schwann cells in transgenic mice with increased PMP22 gene dosage. J Neurosci. 16:1996;5351-5360.
19. McHanwell S., Biscoe T.J. The localization of motoneurons supplying the hindlimb muscles of the mouse. Proc R Soc Lond B Biol Sci. 293:1981;477-508.
20. Naef R., Suter U. Many facets of the peripheral myelin protein PMP22 in myelination and disease. Microsc Res Tech. 1:1998;359-371.
21. Norreel J.C., Jamon M., Rivière G., Passage E., Fontés M., Clarac F. Behavioural profiling of a murine Charcot-Marie-Tooth type 1A model. Eur J Neurosci. 8:2001;1625-1634.
22. Palau F., Löfgren A., De Jonghe P., Bort S., Nelis E., Sevilla T., Martin J.J., Vilchez J., Pietro F., Van Broeckhoven C. Origin of the de novo duplication in Charcot-Marie-Tooth disease type 1A unequal nonsister chromatid exchange during spermatogenesis . Hum Mol Genet. 2:1993;2031-2035.
23. Parmantier E., Cabon F., Braun C., D'Urso D., Muller H.W., Zalc B. Peripheral myelin protein-22 is expressed in rat and mouse brain and spinal cord motoneurons. Eur J Neurosci. 7:1994;1080-1088.
24. Pentao L., Wise C.A., Chinault A.C., Patel P.I., Lupski J.R. Charcot-Marie-Tooth type 1A duplication appears to arise from recombination at repeat sequences flanking the 1.5 Mb monomer unit. Nature Genet. 2:1992;292-300.
25. Perea J., Robertson A., Tolmachova T., Muddle J., King R.H., Ponsford S., Thomas P.K., Huxley C. Induces myelination and demyelination in a conditional mouse model of Charcot-Marie-Tooth type 1A. Hum Mol Genet. 10:2001;1007-1018.
26. Sagot Y., Rosse T., Vejsada R., Perrelet D., Kato A.C. Differential effect of neurotrophic factors on motoneuron retrograde labeling in a murine model of motoneuron disease. J Neurosci. 18:1998;1132-1141.
27. Sancho S., Magyar J.P., Aguzzi J.P., Suter U. Distal axonopathy in peripheral nerves of PMP22-mutant mice. Brain. 122:1999;1563-1577.
28. Sereda M., Griffiths I., Puhlhofer A., Stewart H., Rossner M.J., Zimmerman F., Magyar J.P., Schneider A., Hund E., Meinck H.M., Suter U., Nave K.A. A transgenic rat model of the Charcot-Marie-Tooth disease. Neuron. 16:1996;1049-1060.
29. Skre H. Genetic and clinical aspects of Charcot-Marie-Tooth disease. Clin Genet. 6:1974;98-118.
30. Suter U., Welcher A.A., Ozcelik T., Snipes G.J., Kosaras B., Francke U., Billings G.S., Sidman R.L., Shooter E.M. Trembler mouse carries a point mutation in a myelin gene. Nature. 356:1992;241-244.
31. Suter U., Moskow J.J., Welcher A.A., Snipes G.J., Kosaras B., Sidman R.L., Buchberg A.M., Shooter E.M. A leucine-to-proline mutation in the putative first transmembrane domaine of the 22Kda peripheral myelin protein in the trembler-J mouse. Proc Natl Acad Sci USA. 89:1992;4382-4386.
32. Suter U., Snipes J. Biology and hereditary motor and sensory neuropathies. Annu Rev Neurosci. 18:1995;45-75.
33. Suter U., Nave K.A. Transgenic mouse models of CMT1A and HNPP. Ann NY Acad Sci. 883:1999;247-253.
34. Taylor V., Welcher A.A., Program A.E., Suter U. Epithelial membrane protein-1, peripheral myelin protein 22, and lens membrane protein 20 define a novel gene family. J Biol Chem. 270:1995;28824-28832.
35. Thomas P.K., Marques W., Davis M.B., Sweeney M.G., King R.H.M., Bradley J.L., Muddle J.R., Tyson J., Malcolm S., Harding A.E. The phenotypic manifestations of chromosome 17p11.2 duplication. Brain. 120:1997;465-478.
36. Young P., Suter U. Disease mechanisms and potential therapeutic strategies in Charcot-Marie-Tooth disease. Brain Res Brain Res Rev. 36:2001;213-221.